PH22471A - Acetyl erythromycin stearate and compositions containing it - Google Patents
Acetyl erythromycin stearate and compositions containing itInfo
- Publication number
- PH22471A PH22471A PH31689A PH31689A PH22471A PH 22471 A PH22471 A PH 22471A PH 31689 A PH31689 A PH 31689A PH 31689 A PH31689 A PH 31689A PH 22471 A PH22471 A PH 22471A
- Authority
- PH
- Philippines
- Prior art keywords
- compositions containing
- erythromycin stearate
- acetyl erythromycin
- acetyl
- stearate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK5884A DK149776C (da) | 1984-01-06 | 1984-01-06 | Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH22471A true PH22471A (en) | 1988-09-12 |
Family
ID=8089251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH31689A PH22471A (en) | 1984-01-06 | 1985-01-07 | Acetyl erythromycin stearate and compositions containing it |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US4599326A (ja) |
| JP (1) | JPS60158197A (ja) |
| KR (1) | KR900006237B1 (ja) |
| AT (1) | AT386414B (ja) |
| AU (1) | AU565688B2 (ja) |
| BE (1) | BE901411A (ja) |
| BG (1) | BG43189A3 (ja) |
| CA (1) | CA1224461A (ja) |
| CH (1) | CH666275A5 (ja) |
| CS (1) | CS247191B2 (ja) |
| CY (1) | CY1462A (ja) |
| DE (1) | DE3500179A1 (ja) |
| DK (1) | DK149776C (ja) |
| ES (1) | ES8605818A1 (ja) |
| FI (1) | FI77249C (ja) |
| FR (1) | FR2557878B1 (ja) |
| GB (1) | GB2152502B (ja) |
| HK (1) | HK11590A (ja) |
| HU (1) | HU196221B (ja) |
| IE (1) | IE57967B1 (ja) |
| IL (1) | IL73885A (ja) |
| IS (1) | IS2968A7 (ja) |
| IT (1) | IT1184304B (ja) |
| KE (1) | KE3841A (ja) |
| LU (1) | LU85721A1 (ja) |
| MA (1) | MA20316A1 (ja) |
| MX (1) | MX156277A (ja) |
| NL (1) | NL8403979A (ja) |
| NO (1) | NO160263C (ja) |
| NZ (1) | NZ210606A (ja) |
| PH (1) | PH22471A (ja) |
| PL (1) | PL144349B1 (ja) |
| PT (1) | PT79777B (ja) |
| RO (1) | RO91262B (ja) |
| SE (1) | SE461854B (ja) |
| SU (1) | SU1410866A3 (ja) |
| YU (1) | YU44485B (ja) |
| ZA (1) | ZA8410143B (ja) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4863741A (en) * | 1985-03-25 | 1989-09-05 | Abbott Laboratories | Tablet composition for drug combinations |
| US4874614A (en) * | 1985-03-25 | 1989-10-17 | Abbott Laboratories | Pharmaceutical tableting method |
| JP3382159B2 (ja) * | 1998-08-05 | 2003-03-04 | 株式会社東芝 | 情報記録媒体とその再生方法及び記録方法 |
| CA2491572C (en) * | 2002-07-05 | 2010-03-23 | Collegium Pharmaceutical, Inc. | Abuse-deterrent pharmaceutical compositions of opiods and other drugs |
| US10004729B2 (en) | 2002-07-05 | 2018-06-26 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| US8840928B2 (en) | 2002-07-05 | 2014-09-23 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| JP2007509971A (ja) * | 2003-10-31 | 2007-04-19 | アルザ・コーポレーシヨン | メトホルミンの増加された吸収のための組成物及び投与形態物 |
| SI1765292T1 (en) | 2004-06-12 | 2018-04-30 | Collegium Pharmaceutical, Inc. | Formulations of medicines to discourage abuse |
| US9895444B2 (en) | 2004-08-25 | 2018-02-20 | Aegis Therapeutics, Llc | Compositions for drug administration |
| WO2006025882A2 (en) | 2004-08-25 | 2006-03-09 | The Uab Research Foundation | Absorption enhancers for drug administration |
| CA2743725A1 (en) | 2006-06-23 | 2007-12-27 | Aegis Therapeutics, Llc | Stabilizing alkylglycoside compositions and methods thereof |
| US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
| EP2709645B1 (en) | 2011-05-18 | 2023-08-09 | Eumederis Pharmaceuticals, Inc. | Improved peptide pharmaceuticals |
| US10005817B2 (en) | 2012-11-20 | 2018-06-26 | Eumederis Pharmaceuticals, Inc. | Peptide pharmaceuticals |
| JP6525456B2 (ja) | 2012-11-20 | 2019-06-05 | メデリス ダイアビーティーズ，エルエルシー | インスリン抵抗性のための改善されたペプチド製剤 |
| WO2014140699A1 (en) * | 2013-03-13 | 2014-09-18 | Calyx Chemicals And Pharmaceuticals Ltd | A novel process of liberation of erythromycin and preparation of its salts |
| CN117180445A (zh) | 2014-05-28 | 2023-12-08 | 梅德瑞斯糖尿病有限责任公司 | 针对胰岛素抵抗的改良肽药物 |
| US9737530B1 (en) | 2016-06-23 | 2017-08-22 | Collegium Pharmaceutical, Inc. | Process of making stable abuse-deterrent oral formulations |
| KR20200010343A (ko) | 2017-05-19 | 2020-01-30 | 루넬라 바이오테크 인코포레이티드 | 안티미토신: 암 줄기 세포를 근절하기 위한 미토콘드리아 생물발생의 표적화 억제제 |
| WO2019108729A1 (en) | 2017-12-01 | 2019-06-06 | Lunella Biotech, Inc. | Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells |
| WO2019157099A1 (en) | 2018-02-06 | 2019-08-15 | Aegis Therapeutics, Llc | Intranasal epinephrine formulations and methods for the treatment of disease |
| DE112019000683T5 (de) | 2018-02-06 | 2020-10-15 | Aegis Therapeutics, Llc | Intranasale epinephrin-formulierungen und verfahren zur behandlung von erkrankungen |
| WO2020131696A1 (en) * | 2018-12-17 | 2020-06-25 | Lunella Biotech, Inc. | Triple combination therapies for targeting mitochondria and killing cancer stem cells |
| CN113453690A (zh) * | 2018-12-17 | 2021-09-28 | 卢内拉生物技术有限公司 | 用于抗衰老的三联疗法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1011117B (de) * | 1953-11-16 | 1957-06-27 | Abbott Lab | Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen |
| FR1179208A (fr) * | 1953-11-16 | 1959-05-21 | Abbott Lab | Procédé de préparation de sels d'érythromycine |
| GB834397A (en) * | 1958-07-29 | 1960-05-04 | Lilly Co Eli | Therapeutic compositions comprising erythromycin esters |
| US4150220A (en) * | 1977-02-04 | 1979-04-17 | Pfizer Inc. | Semi-synthetic 4"-erythromycin A derivatives |
| FR2473525A1 (fr) * | 1980-01-11 | 1981-07-17 | Roussel Uclaf | Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments |
-
1984
- 1984-01-06 DK DK5884A patent/DK149776C/da not_active IP Right Cessation
- 1984-12-18 NZ NZ210606A patent/NZ210606A/en unknown
- 1984-12-20 IL IL73885A patent/IL73885A/xx not_active IP Right Cessation
- 1984-12-21 GB GB08432368A patent/GB2152502B/en not_active Expired
- 1984-12-21 AU AU37059/84A patent/AU565688B2/en not_active Ceased
- 1984-12-27 US US06/686,753 patent/US4599326A/en not_active Expired - Fee Related
- 1984-12-28 IS IS2968A patent/IS2968A7/is unknown
- 1984-12-28 BE BE0/214265A patent/BE901411A/fr not_active IP Right Cessation
- 1984-12-28 SE SE8406671A patent/SE461854B/sv not_active IP Right Cessation
- 1984-12-28 PT PT79777A patent/PT79777B/pt not_active IP Right Cessation
- 1984-12-28 ZA ZA8410143A patent/ZA8410143B/xx unknown
- 1984-12-31 NL NL8403979A patent/NL8403979A/nl not_active Application Discontinuation
-
1985
- 1985-01-02 MA MA20540A patent/MA20316A1/fr unknown
- 1985-01-02 NO NO850007A patent/NO160263C/no unknown
- 1985-01-02 FR FR8500005A patent/FR2557878B1/fr not_active Expired
- 1985-01-03 FI FI850023A patent/FI77249C/fi not_active IP Right Cessation
- 1985-01-03 AT AT0000985A patent/AT386414B/de not_active IP Right Cessation
- 1985-01-04 IE IE22/85A patent/IE57967B1/en not_active IP Right Cessation
- 1985-01-04 DE DE19853500179 patent/DE3500179A1/de active Granted
- 1985-01-04 IT IT19012/85A patent/IT1184304B/it active
- 1985-01-04 LU LU85721A patent/LU85721A1/fr unknown
- 1985-01-04 KR KR1019850000008A patent/KR900006237B1/ko not_active IP Right Cessation
- 1985-01-04 HU HU8537A patent/HU196221B/hu not_active IP Right Cessation
- 1985-01-04 PL PL1985251457A patent/PL144349B1/pl unknown
- 1985-01-04 CH CH31/85A patent/CH666275A5/de not_active IP Right Cessation
- 1985-01-04 SU SU853836820A patent/SU1410866A3/ru active
- 1985-01-04 CS CS8596A patent/CS247191B2/cs unknown
- 1985-01-04 ES ES539349A patent/ES8605818A1/es not_active Expired
- 1985-01-04 CA CA000471563A patent/CA1224461A/en not_active Expired
- 1985-01-04 YU YU20/85A patent/YU44485B/xx unknown
- 1985-01-05 BG BG068285A patent/BG43189A3/xx unknown
- 1985-01-07 RO RO117230A patent/RO91262B/ro unknown
- 1985-01-07 JP JP60000744A patent/JPS60158197A/ja active Granted
- 1985-01-07 PH PH31689A patent/PH22471A/en unknown
- 1985-01-07 MX MX203973A patent/MX156277A/es unknown
-
1988
- 1988-10-28 KE KE3841A patent/KE3841A/xx unknown
-
1989
- 1989-07-21 CY CY1462A patent/CY1462A/xx unknown
-
1990
- 1990-02-15 HK HK115/90A patent/HK11590A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH22471A (en) | Acetyl erythromycin stearate and compositions containing it | |
| NZ213463A (en) | Antibiotic compound and compositions | |
| PH24830A (en) | Indolize compounds and compositions containing them | |
| GB2165751B (en) | Pharmaceutical compositions containing anthracycline glycosides | |
| IL74758A (en) | Acyltripeptides and pharmaceutical compositions containing them | |
| NZ211145A (en) | 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions | |
| IL89996A0 (en) | Macrolide compositions | |
| GB8401016D0 (en) | Organopolysiloxane compositions | |
| NZ212005A (en) | Pyrrolobenzimidazoles and pharmaceutical compositions | |
| ZA859339B (en) | Processes and compositions | |
| EP0214102A3 (en) | 5-aralkyl-substituted 2h-benzotriazoles and stabilized compositions | |
| NZ211872A (en) | Chartreusin derivatives and antitumorous compositions | |
| AU519743B2 (en) | Compositions containing erythromycin and metoclopramide | |
| EP0230052A3 (en) | Immunoamplifiers and related compositions | |
| EP0210655A3 (en) | Polystyrene compositions | |
| GB8507503D0 (en) | Acetyl compound | |
| PH23343A (en) | 8 0( acylaminoergolines and pharmaceutical compositions containing them | |
| IL74667A (en) | Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them | |
| GB8514485D0 (en) | Organopolysiloxane compositions | |
| GB2205746B (en) | Beta-glucuronidase containing compositions | |
| NZ219645A (en) | Pyrazoles and gametocidal compositions | |
| GB8507710D0 (en) | Acetyl compound | |
| IE830409L (en) | Oleandomycin and erythromycin derivatives | |
| GB8500263D0 (en) | 4'-deoxy-4'-halodoxorubicin-14-esters | |
| IE842007L (en) | Erythromycine and irosine compositions |